Paclitaxel protein-bound particles for injectable suspension (albumin-bound)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Paclitaxel protein-bound particles for injectable suspension (albumin-bound), covering 2025-05-15 to 2025-05-15. Get the full timeline:
Most recent: FDA Approved: PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION (ALBUMIN-BOUND) — Original Application (BluePoint Laboratories)